SCHEMBL753514

SCHEMBL753514

Cc1ccccc1CS(=O)(=O)C(Br)Br

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 1/20 0.43
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TAAR1 Q96RJ0 1/20 0.39
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
NR3C1 P04150 1/20 0.37
PGR P06401 1/20 0.37
NR3C2 P08235 1/20 0.37
IDO1 P14902 1/20 0.36
TDO2 P48775 1/20 0.36
HPGD P15428 2/20 0.35
CTBP2 P56545 1/20 0.35
CA2 P00918 1/20 0.35
CHRM2 P08172 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754517 0.78 TAAR1 (0.41) ALDH1A1LMNATAAR1IDO1HPGD
SCHEMBL776517 0.77 ALDH1A1 (0.50) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL754045 0.77 ALDH1A1 (0.49) ALDH1A1LMNAKMT2ATAAR1IDO1
SCHEMBL294360 0.75 ALDH1A1 (0.53) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL2376651 0.75 ALDH1A1 (0.49) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL7899861 0.74 FAAH (0.50) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL14378207 0.74 GAA (0.47) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL2376646 0.74 ALDH1A1 (0.47) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL1428960 0.74 ALDH1A1 (0.47) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL4003591 0.74 ALDH1A1 (0.47) ALDH1A1GAALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
EP-2430452-A1 CARCINOMA DIAGNOSIS AND TREATMENTS, BASED ON ODC1 GENOTYPE Arizona Board of Regents on Behalf of University of Arizona (US) 2012-03-21 EP disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M ALDH1A1 553/4885GAA 3827/4885LMNA 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.